The University of Washington in Seattle is using a blue light cystoscopy that makes tumors glow a bright pink color, allowing surgeons to better identify non-muscle-invasive bladder cancer.
The Latest
A new research foundation, Break Through Cancer, will combine research teams from five of the country's leading cancer centers to develop new treatments, advance clinical trials and improve patient outcomes, the organization announced Feb. 25.
Joanne Dragun, MD, is the American College of Radiation Oncology's new president, the group said Feb. 23. Dr. Dragun is the medical director of GenesisCare in Jacksonville, Fla.
The COVID-19 pandemic has introduced challenges to the lives of many oncologists, including outside of the workplace, according to Medscape's 2021 Oncologist Lifestyle, Happiness & Burnout Report published Feb. 19.
Those with gastroesophageal reflux disease face a two times greater risk of developing larynx and esophagus cancers, according to research published Feb. 22 in Cancer.
The overall positive test rate for the SARS-CoV-2 virus across surfaces in a number of oncology units was 0.5 percent, according to research published Feb. 18 in Cancer.
Cancer & Blood Specialists of Arizona will provide care at three new locations in the Phoenix area as part of a partnership with the American Oncology Network, the groups said Feb. 18.
States should follow the CDC's recommendation to include cancer patients as a priority group in their COVID-19 vaccine distribution plans, the Association for Clinical Oncology and the American Cancer Society Cancer Action Network said in a joint letter to governors…
An oncologist group has lost a bid to have a court review its legal challenge to an automatic 2 percent cut in Medicare reimbursement that began seven years ago for intravenous cancer treatments and other drugs, according to Bloomberg Law.
Boston-based Dana-Farber Cancer Institute became the newest member of Caris Life Sciences' Precision Oncology Alliance Feb. 16.